{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05986864",
            "orgStudyIdInfo": {
                "id": "SKG0106-101"
            },
            "organization": {
                "fullName": "Skyline Therapeutics",
                "class": "INDUSTRY"
            },
            "briefTitle": "Phase I/II Study of SKG0106 Intravitreal Injection in Patients With Neovascular Age-related Macular Degeneration (nAMD)",
            "officialTitle": "Phase I/II Study to Evaluate the Safety and Preliminary Efficacy of SKG0106 Intravitreal Injection in Patients With Neovascular Age-related Macular Degeneration (nAMD)",
            "therapeuticArea": [
                "Ophthalmology"
            ],
            "study": "phase-i-ii-study-of-intravitreal-injection-in-patients-with-neovascular-age-related-macular-degeneration-namd"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-01",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-02-23",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-01",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-01-30",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-08-03",
            "studyFirstSubmitQcDate": "2023-08-03",
            "studyFirstPostDateStruct": {
                "date": "2023-08-14",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-06-27",
            "lastUpdatePostDateStruct": {
                "date": "2024-06-28",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Skyline Therapeutics (US) Inc.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "This is a phase 1/2 clinical study to evaluate the safety, preliminary efficacy, immunogenicity, and pharmacokinetic (PK) characteristics of SKG0106 in subjects with nAMD. Based on results from the phase 1 dose escalation study, the phase 2 expansion study will be conducted."
        },
        "conditionsModule": {
            "conditions": [
                "Neovascular Age-related Macular Degeneration"
            ],
            "keywords": [
                "AMD",
                "wet AMD",
                "wAMD",
                "nAMD"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1",
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 68,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Phase I: Low dose",
                    "type": "EXPERIMENTAL",
                    "description": "SKG0106 One-Time Intraocular Injection Dose Level 1",
                    "interventionNames": [
                        "Genetic: SKG0106"
                    ]
                },
                {
                    "label": "Phase I: Medium dose",
                    "type": "EXPERIMENTAL",
                    "description": "SKG0106 One-Time Intraocular Injection Dose Level 2",
                    "interventionNames": [
                        "Genetic: SKG0106"
                    ]
                },
                {
                    "label": "Phase I: High dose",
                    "type": "EXPERIMENTAL",
                    "description": "SKG0106 One-Time Intraocular Injection Dose Level 3",
                    "interventionNames": [
                        "Genetic: SKG0106"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "GENETIC",
                    "name": "SKG0106",
                    "description": "SKG0106 is a recombinant adeno-associated virus (AAV) vector-based in vivo gene therapeutic product",
                    "armGroupLabels": [
                        "Phase I: High dose",
                        "Phase I: Low dose",
                        "Phase I: Medium dose"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Characteristics of dose limiting toxicities (DLTs)",
                    "timeFrame": "4 Weeks"
                },
                {
                    "measure": "Type, severity, and incidence of ocular and systemic adverse events (AEs)",
                    "timeFrame": "52 Weeks"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Mean change from baseline in best corrected visual acuity (BCVA) at each visit",
                    "description": "BCVA of the study eye is examined by the Early Treatment of Diabetic Retinopathy Study (ETDRS) testing at screening and baseline.",
                    "timeFrame": "52 Weeks"
                },
                {
                    "measure": "Mean change from baseline in central subfield thickness (CST) at each visit",
                    "description": "Spectral domain optical coherence tomography (SD-OCT) will be performed to measure CST at screening and at each visit (prior to study drug injection, if available).",
                    "timeFrame": "52 Weeks"
                },
                {
                    "measure": "Mean change from baseline in patient-reported outcome (VFQ-25) scale score at each visit",
                    "description": "Both the total scale and subscale scores of the VFQ-25 is ranging from 0 to 100, and higher scores mean a better outcome.",
                    "timeFrame": "52 Weeks"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion criteria:\n\n1. Voluntary and able to sign a dated ICF prior to any study-related procedures and able to complete the study as required by the protocol;\n2. Aged \u2265 50 years at screening;\n\n   Study Eye:\n3. Diagnosis of nAMD as determined by the PI;\n4. Active CNV lesions secondary to age-related macular degeneration (AMD);\n5. Subjects must have been responsive to anti-VEGF therapy as assessed by the PI prior to study treatment.\n\nExclusion Criteria:\n\n1. Any active intraocular or periocular infection or active intraocular inflammation (e.g., infectious conjunctivitis, keratitis, scleritis, endophthalmitis, infectious blepharitis, uveitis) in the study eye at baseline;\n2. Retinal pigment epithelial tear in the study eye at screening;\n3. Current vitreous hemorrhage in the study eye or history of vitreous hemorrhage within 4 weeks prior to baseline;\n4. Any condition that, in the opinion of the investigator, may limit visual acuity improvement in the study eye;\n5. History of retinal detachment or active retinal detachment in the study eye;\n6. Any prior gene therapy.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "50 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Yongqin Wang",
                    "role": "CONTACT",
                    "phone": "+86 18616737445",
                    "email": "yongqin.wang@skytx.com"
                }
            ],
            "locations": [
                {
                    "facility": "Ophthalmic Consultants of Boston",
                    "status": "RECRUITING",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02114",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                },
                {
                    "facility": "Retina Consultants of Texas",
                    "status": "RECRUITING",
                    "city": "Katy",
                    "state": "Texas",
                    "zip": "77494",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Marie Chin",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Charles C Wykoff, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.78579,
                        "lon": -95.8244
                    }
                },
                {
                    "facility": "Wagner Kapoor Research Institute",
                    "status": "RECRUITING",
                    "city": "Norfolk",
                    "state": "Virginia",
                    "zip": "23502",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Chris Riebling",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Alan Wagner, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 36.84681,
                        "lon": -76.28522
                    }
                },
                {
                    "facility": "The Second Hospital Of Anhui Medical University",
                    "status": "RECRUITING",
                    "city": "Hefei",
                    "state": "Anhui",
                    "country": "China",
                    "geoPoint": {
                        "lat": 31.86389,
                        "lon": 117.28083
                    }
                },
                {
                    "facility": "Zhejiang Provincial People's Hospital",
                    "status": "RECRUITING",
                    "city": "Hangzhou",
                    "state": "Zhejiang",
                    "country": "China",
                    "geoPoint": {
                        "lat": 30.29365,
                        "lon": 120.16142
                    }
                },
                {
                    "facility": "Eye Hospital, WMU (Zhejiang Eye Hospital)",
                    "status": "RECRUITING",
                    "city": "Wenzhou",
                    "state": "Zhejiang",
                    "country": "China",
                    "geoPoint": {
                        "lat": 27.99942,
                        "lon": 120.66682
                    }
                },
                {
                    "facility": "Beijing Hospital",
                    "status": "RECRUITING",
                    "city": "Beijing",
                    "country": "China",
                    "geoPoint": {
                        "lat": 39.9075,
                        "lon": 116.39723
                    }
                },
                {
                    "facility": "Peking Union Medical College Hospital",
                    "status": "RECRUITING",
                    "city": "Beijing",
                    "country": "China",
                    "geoPoint": {
                        "lat": 39.9075,
                        "lon": 116.39723
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000008268",
                    "term": "Macular Degeneration"
                },
                {
                    "id": "D000057135",
                    "term": "Wet Macular Degeneration"
                }
            ],
            "ancestors": [
                {
                    "id": "D000012162",
                    "term": "Retinal Degeneration"
                },
                {
                    "id": "D000012164",
                    "term": "Retinal Diseases"
                },
                {
                    "id": "D000005128",
                    "term": "Eye Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M11260",
                    "name": "Macular Degeneration",
                    "asFound": "Age-related Macular Degeneration",
                    "relevance": "HIGH"
                },
                {
                    "id": "M28735",
                    "name": "Wet Macular Degeneration",
                    "asFound": "Neovascular Age-related Macular Degeneration",
                    "relevance": "HIGH"
                },
                {
                    "id": "M14997",
                    "name": "Retinal Degeneration",
                    "relevance": "LOW"
                },
                {
                    "id": "M14999",
                    "name": "Retinal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8271",
                    "name": "Eye Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC11",
                    "name": "Eye Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        }
    },
    "hasResults": false
}